Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
Abroad (travel likely)Recruiting
Conditions
Glioblastoma · Radiotherapy · Chemotherapy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU Amiens Picardie, Amiens, Picardie, France
Contact: Study coordinator (Jean-Marc CONSTANS, PhD) · constans.jean-marc@chu-amiens.fr · +33322087511